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OBJECTIVES We hypothesized that recognition of systolic flow reversal (pulsatile flow) after thrombolytic
administration on coronary angiography is associated with angiographic and electrocardio-
gram findings reflecting impaired myocardial perfusion, as well as poorer clinical outcomes.
BACKGROUND Reversal of systolic flow on Doppler velocity wire recordings has been associated with
impaired tissue perfusion on myocardial contrast echocardiography in the setting of
myocardial infarction (MI).
METHODS Patients (n  1,062) with a patent infarct-related artery were drawn from the Thrombolysis
In Myocardial Infarction (TIMI) 10, TIMI 14, and Integrillin and Tenecteplase acute MI
trials.
RESULTS Pulsatile flow (systolic flow reversal with cessation of antegrade contrast-dye motion or
frank reversal of contrast-dye motion during systole) at 60 min after fibrinolytic
administration was present in 11.0% of patients. Pulsatile flow was associated with higher
corrected TIMI frame counts (slower epicardial flow) (median 40.1 frames, IQ 30 of 63
vs. 30 frames, interquartile 22 of 42, p  0.0001), a closed microvasculature (TIMI
myocardial perfusion grades 0 of 1, 57.1% vs. 37.8%, p  0.03) and less complete (70%)
ST-segment resolution (23.5% vs. 58.9%, p  0.008). Patients with pulsatile flow had a
higher risk of death or reinfarction at 30 days (10.3% vs. 5.0%, p  0.019). After
controlling for age, pulse, blood pressure, anterior MI location, epicardial flow, and
creatine kinase, pulsatile flow remained associated with an increased risk of death/MI
(odds ratio 3.1, p  0.006).
CONCLUSIONS A pulsatile pattern of flow is associated with impaired myocardial perfusion and poorer
clinical outcomes independent of the velocity of antegrade flow in the epicardial artery. This
simple and easily identifiable angiographic flow pattern may be useful in clinical risk
stratification. (J Am Coll Cardiol 2004;43:1170–6) © 2004 by the American College of
Cardiology FoundationD
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bhe open artery hypothesis calls for early, complete, and
ustained restoration of blood flow in the culprit epicardial
rtery in ST-elevation myocardial infarction (STEMI).
owever, despite the presence of normal epicardial Throm-
olysis In Myocardial Infarction (TIMI) grade 3 flow
TFG), impaired myocardial perfusion on coronary arte-
iography has also been independently associated with
ncreased mortality (1). Other tools to interrogate the
icrovasculature have, likewise, underscored the impor-
ance of restoring microvascular perfusion. For instance,
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rom Genentech, Inc., South San Francisco, California (TIMI 10A and TIMI 10B);
illennium Pharmaceuticals, Cambridge, Massachusetts, and Schering-Plough Re-
earch Institute in Kenilworth, New Jersey (INTEGRITI); Centocor, Malvern,
ennsylvania, and Eli Lilly, Inc., Indianapolis, Indiana (TIMI 14).
Manuscript received August 13, 2003; revised manuscript received October 8,003, accepted November 13, 2003.oppler velocity studies have demonstrated an association
etween systolic flow reversal in the epicardial coronary
rtery with dysfunction in the myocardial microvasculature
n myocardial contrast echocardiography (2). Furthermore,
ystolic flow reversal on Doppler velocity studies that
ersists after primary percutaneous coronary intervention
PCI) has also been associated with increased in-hospital
ortality (3).
While these observations have relied upon the technology
f Doppler velocity wires, pulsatile flow (flow reversal with
essation of antegrade contrast-dye motion or frank reversal
f contrast-dye motion during systole) can also be evaluated
isually on the coronary arteriogram. We have previously
emonstrated that the simple pattern of pulsatile flow on
he coronary angiogram is associated with higher culprit
rtery corrected TIMI frame counts (CTFC) (i.e., slower
lood flow) (4). We also observed that pulsatile flow in the
ulprit artery was associated with slower flow in the distri-
ution of the nonculprit artery and that pulsatile flow in the
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April 7, 2004:1170–6 Pulsatile Flow and Clinical Outcomesonculprit artery is also associated with slower flow in the
onculprit artery (5).
The association of pulsatile flow in the epicardial artery
nd tissue perfusion on the angiogram has not been evalu-
ted. We hypothesized that pulsatile flow after thrombolytic
dministration would be associated with impaired myocar-
ial tissue-level perfusion on coronary arteriography, poorer
lectrocardiographic ST-segment resolution, and its detec-
ion could be used as an adjunct in clinical risk stratification.
ETHODS
atients with suitable coronary angiograms and a patent
picardial culprit artery (TFG 2 of 3) (n  1,062) were
rawn from a total of 2,600 patients enrolled in the trials.
atients included were from TIMI 10A (n  23), TIMI
0B (n  361), TIMI 14 (n  369), and Integrillin and
enecteplase (INTEGRITI) (n  309) acute MI trials.
he TIMI 10A trial was a nonrandomized, open-label,
ose escalation study of eight ascending doses of tenect-
plase (TNK) (6). Thrombolysis in Myocardial Infarction
0B was a randomized trial comparing various doses of
NK with front-loaded rt-PA (7). The TIMI 14 trial
ompared abciximab plus reduced-dose thrombolytic
gent versus full-dose thrombolytic agent (8,9). The
NTEGRITI trial randomized acute ST-elevation MI
atients prospectively to a combination of eptifibatide
nd reduced dose tenecteplase (TNK) versus full dose
NK (10).
The presence of a pulsatile flow pattern on the angio-
ram at 60 min (range, 55 to 75 min) after study drug
dministration was assessed visually by a single experi-
nced observer (C.M.G.) blinded to treatment assign-
ent and clinical outcomes. A pulsatile flow pattern was
efined as cessation of antegrade contrast-dye motion or
rank reversal of contrast-dye motion during systole. The
resence or absence of a pulsatile flow pattern was also
ssessed on the angiogram after PCI. The TFG, CTFC,
nd TIMI myocardial perfusion grade (TMPG) were
ssessed (1,11,12).
The magnitude of ST-segment resolution and the fre-
uency of complete (70%) ST-segment resolution on the
2-lead electrocardiogram (ECG) at 60 min compared with
Abbreviations and Acronyms
CTFC  corrected TIMI frame count
INTEGRITI  Integrillin and Tenecteplase in Acute
Myocardial Infarction trial
LAD  left anterior descending artery
PCI  percutaneous coronary intervention
STEMI  ST-elevation myocardial infarction
TFG  TIMI flow grade
TIMI  Thrombolysis In Myocardial Infarction
TMPG  TIMI myocardial perfusion grade
TNK  tenecteplasehe baseline ECG were determined by the TIMI Electro- Fardiographic Core Laboratory (Boston, Massachusetts),
linded to treatment assignment and clinical and angio-
raphic findings, using previously established techniques
13). Recurrent MI was diagnosed by local investigators,
xcept in TIMI 14 where it was adjudicated by a clinical
vents committee. Recurrent MI was defined as previously
escribed (6–10). Cardiac biomarker determination was
erformed at each site’s local laboratory, and the data are
eported as multiples of the upper reference limit of the
articular laboratory that analyzed the sample. All studies
ere approved by each participating center’s institutional
eview board, and the trials were conducted according to the
rinciples of the Declaration of Helsinki.
tatistical analysis. All analyses were performed using
tata version 7.0 (Stata Corp., College Station, Texas). All
ontinuous variable values are reported as the mean SD or
edian where appropriate. Student t test was used for the
nalysis of continuous variables. The nonparametric Wil-
oxon rank sum test was used for the CTFC analysis
ecause a value of 100 was imputed to an occluded vessel.
he chi-square test was used for the analysis of categorical
ariables when sample size was 5 for all cells in a table.
hen the sample size was 5 in a given cell of a table,
isher exact test was used. A multivariate logistic regression
odel was used for the analysis of death or MI by 30 days.
Kaplan-Meier curve was generated for recurrent MI
hrough 30-day follow-up by pulsatile flow pattern. The
og-rank test was used to test the equality of the survivor
unction by pulsatile flow pattern.
ESULTS
total of 1,062 patients with an open epicardial culprit
rtery (TFG 2 or 3) on the angiogram 60 min after study
rug administration were included in the analysis. Pulsatile
ow was present in 117 patients (11.0%), and the remainder
945, 89.0%) had normal antegrade culprit coronary artery
ow during the entire cardiac cycle. Patients with pulsatile
ow were younger and had a higher heart rate on presen-
ation (Table 1). Pulsatile flow was more frequent if the
ulprit artery was the left anterior descending (LAD) artery
nd if angiographically apparent thrombus was present.
atients treated with combination therapy of platelet gly-
oprotein IIb/IIIa inhibitor plus reduced dose fibrinolytic
gent tended to less frequently have pulsatile flow compared
ith patients treated with fibrinolytic monotherapy (9.5%,
7 of 494 vs. 12.4%, 70 of 567, p  0.14). Patients with
ulsatile flow tended to have higher median peak creatine
inase values compared with patients with nonpulsatile flow
Table 1).
The incidence of TIMI grade 2 flow was increased
mong patients with pulsatile flow on the 60-min angio-
ram (Fig. 1). Likewise, the median CTFC among patients
ith pulsatile flow pattern was higher (slower flow) com-
ared with patients with nonpulsatile flow pattern (Fig. 2).
urthermore, the presence of pulsatile flow was associated
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Pulsatile Flow and Clinical Outcomes April 7, 2004:1170–6ith a higher incidence of closed microvasculature com-
ared with nonpulsatile flow (TMPG 0 of 1, 57.1%, 20 of
5 vs. 37.8%, 113 of 299, p 0.03, Fig. 3). All angiographic
Table 1. Baseline Clinical and Angiographic C
Variables
Pulsatile Flow
(n  117)
Age, yrs 54.9 ( 10.9)
Male gender, % 84.6
Hypertension, % 31.6
Diabetes, % 13.7
Current smoker, % 50.4
Prior MI, % 9.4
Heart rate, beats/min 78.9 ( 16.9)
SBP, mm Hg 138.4 ( 22.1)
Time to therapy, h 3.3 ( 1.8)
Thrombus, % 29.8
LAD location % 69.2
Multivessel disease, % 41.4
Median peak CK/ULN 9.4 (2.9, 20.5
LVEF, % 56.8 ( 15.2)
Age, heart rate, SBP, time to therapy, and LVEF values are
median (25th percentile, 75th percentile).
CK  creatine kinase; LAD  left anterior descendin
infarction; SBP  systolic blood pressure; ULN  upper lim
igure 1. (A) Incidence of 60-min Thrombolysis In Myocardial Infarction
TIMI) grade 2 flow among patients with pulsatile versus nonpulsatile flow
attern. (B) Incidence of pulsatile flow among patients with TIMI flow
rade (TFG) 2 and grade 3 at 60 min. PCI  percutaneous coronaryuntervention.nalyses (TFG, CTFC, TMPG) were similar for both LAD
nd non-LAD culprit arteries. Pulsatile flow resolved in
6.7% (24 of 36) patients after the performance of PCI. On
he other hand, 4.1% (12 of 296) of the patients who had
onpulsatile flow before PCI developed new pulsatile flow
fter PCI.
The incidence of complete (70%) ST-segment resolution
n a static 12-lead ECG 60 min after study drug administra-
ion was reduced among patients with pulsatile flow (23.5%, 4
f 17 vs. 58.9%, 86 of 146, p 0.008 by Fisher exact test, Fig.
). Likewise, the median extent of ST-segment resolution at
0 min was lower among patients with pulsatile flow (median
5.7%, IQ range 40/68%, n  17 vs. median 79.1%, IQ
6/93%, n  146, p  0.011, Fig. 4).
A pulsatile pattern of coronary blood flow on the 60-min
ngiogram was associated with a higher incidence of death
r recurrent MI at 30 days compared with patients with
onpulsatile flow: 10.3% (12 to 117) versus 5.0% (47 of
42), p  0.019 (Fig. 5). A nonsignificant trend for this
ssociation persisted even among patients who subsequently
nderwent a PCI (7.1%, 3 of 42 vs. 3.0%, 10 of 334, p 
.17 by Fisher exact test). The presence of a pulsatile flow
attern on the 60-min angiogram remained independently
ssociated with a higher incidence of 30-day death or
ecurrent MI (odds ratio, 3.1, p  0.006) after adjusting for
ge, heart rate, systolic blood pressure, LAD culprit loca-
ion, TFG 3 epicardial blood flow, and peak creatine kinase.
his composite end point was driven largely by the risk of
ecurrent MI, which differed significantly by pulsatile pat-
ern (pulsatile 7.8%, 9 of 116 vs. nonpulsatile 2.8%, 26 of
25, p 0.005; Fig. 6) rather than by death (pulsatile 2.6%,
of 117 vs. nonpulsatile 2.4%, 23 of 941, p  1.0 by Fisher
xact). In a multivariate model adjusting for previously
dentified correlates of angiographic reocclusion (TFG,
AD, thrombus, percent diameter stenosis, eccentric lesion,
cteristics
Nonpulsatile Flow
(n  945) p Value
58.7 ( 10.7)  0.001
76.8 0.056
32.3 0.88
13.6 0.98
50.5 0.98
13.4 0.22
75.3 ( 17.2) 0.03
140.0 ( 21.5) 0.44
3.5 ( 3.1) 0.82
20.8 0.027
32.5  0.001
55.3 0.005
7.2 (3.5, 13.4) 0.12
58.2 ( 15.4) 0.47
d as mean ( SD). Median peak CK values are reported as
EF  left ventricular ejection fraction; MI  myocardial
normal.hara
)
reporte
g; LVlcerated lesion, and collaterals) (14) and clinical reinfarc-
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April 7, 2004:1170–6 Pulsatile Flow and Clinical Outcomesion (age and performance of adjunctive PCI) (15), a
ulsatile flow pattern remained associated with recurrent
I by 30 days (odds ratio, 5.2; p  0.001). Similar results
or pulsatile flow were observed when CTFC was included
n the model instead of TFG 3 (odds ratio, 2.8; p  0.017
or death/MI and odds ratio, 3.7; p  0.015 for MI).
ISCUSSION
his study demonstrates that a pulsatile pattern of coronary
lood flow is associated with impaired myocardial perfusion
nd poorer clinical outcomes. Prior studies have demon-
trated that impaired epicardial blood flow, LAD culprit
rtery location, and multivessel or left main disease are all
ngiographic variables that are associated with poorer clin-
cal outcomes after fibrinolytic administration for acute
TEMI (1,14–18). This study extends these observations to
emonstrate that a pulsatile pattern of epicardial blood flow
igure 2. (A) Median 60-min corrected Thrombolysis In Myocardial Infa
ulsatile versus nonpulsatile flow pattern. p value from Wilcoxon rank-sum
edian (30.6 frames) (CTFC) at 60 min.s also associated with adverse clinical outcomes. A pulsatile aow pattern was associated with higher incidence of death
r recurrent MI at 30 days even after adjusting for other
onfounding variables. In a multivariate model adjusting for
reviously identified correlates of angiographic reocclusion
14) (TFG, LAD, thrombus, percent diameter stenosis,
ccentric lesion, ulcerated lesion, or collaterals) and clinical
einfarction (15) (PCI and age), the presence of pulsatile
ow was associated with a highly significant fivefold in-
rease in the risk of reinfarction. This simple and easily
dentifiable angiographic flow pattern may be useful in
linical risk stratification.
Pulsatile flow was associated with impaired myocardial
erfusion as assessed by the TMPG on the angiogram and
y reduced ST-segment resolution. Distal embolization and
he release of vasoconstrictors may explain, at least in part,
he impairment in myocardial perfusion. Indeed, visible
ntracoronary thrombus was more commonly present among
(TIMI) frame count (CTFC) with interquartile range for patients with
. (B) Incidence of pulsatile flow among patients with above versus belowrction
testrteries with a pulsatile flow pattern. Combination therapy
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Pulsatile Flow and Clinical Outcomes April 7, 2004:1170–6ith platelet glycoprotein IIb/IIIa inhibitors and reduced-
ose thrombolytic agents have been associated with a
eduction in thrombus burden (19), and it is notable that the
dministration of glycoprotein IIb/IIIa inhibitors tended to
e associated with a reduced incidence of pulsatile flow on
he 60-min angiogram.
Pulsatile flow was also observed more frequently among
atients in whom the LAD was the culprit vessel. The
nfarcts in these patients are characterized by a greater
olume of myocardium distal to the stenosis (4), a thicker
yocardium compared with the right coronary artery, and
igher left ventricular filling pressures compared with right
entricular filling pressures. As a result of this, it could be
peculated that the greater myocardial edema and conse-
uent extrinsic compression of the capillary network as well
s the higher left ventricular filling pressures that develop
mong patients with anterior infarction may play a role in
ulsatile flow. Indeed, systolic flow reversal occurs when the
ownstream microvascular pressure during systole exceeds
he upstream epicardial artery pressure. While pulsatile flow
s associated with larger infarct sizes (larger peak creatine
inase levels), the directionality of the causal relationship is
igure 3. (A) Incidence of TIMI myocardial perfusion grade (TMPG) 0 to
at 60 min among patients with pulsatile versus nonpulsatile flow pattern.
B) Incidence of pulsatile flow among patients with TMPG 0 to 1 versus
MPG 2 to 3 at 60 min.nknown; it is not clear if larger myocardial infarctionsause pulsatile flow, or if pulsatile flow (a surrogate for
eightened downstream microvascular resistance), in turn,
auses larger myocardial infarctions.
igure 4. (A) Incidence of complete (70%) ST-segment resolution (ST
es) at 60 min among patients with pulsatile versus nonpulsatile flow
attern. p value from Fisher exact test. (B) Incidence of pulsatile flow
mong patients with complete (70%) versus incomplete ST Res at 60
in. p value from Fisher exact test. (C) Median ST Res with interquartile
ange at 60 min among patients with pulsatile versus nonpulsatile flow
attern.
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April 7, 2004:1170–6 Pulsatile Flow and Clinical OutcomesAmong patients with pulsatile flow before PCI, flow
eversal was resolved in 66.7% of patients after the perfor-
ance of PCI. Previously we have reported that flow in the
igure 5. (A) Incidence of death or recurrent myocardial infarction (MI) at
0 days among patients with pulsatile versus nonpulsatile flow pattern at 60
in. (B) Incidence of pulsatile flow at 60 min among patients who died or
ustained a recurrent MI within 30 days of the index MI versus patients
ho survived 30 days without recurrent MI.
igure 6. Kaplan-Meier curve for recurrent myocardial infarction through
0 days among patients with pulsatile versus nonpulsatile flow pattern at 60
in.onculprit artery improves after PCI of the culprit artery.
here may be shared abnormalities in the downstream
icrovasculature, some of which may be mediated by
eightened neuroadrenergic tone to maintain perfusion
ressure. This tone is relieved after dilation of the stenosis.
inally, if the pressure beyond the stenosis is low, height-
ned pressure during systole may cause flow to reverse in
his low pressure system.
tudy limitations. This is a retrospective analysis, and
nidentified confounders may have contributed to the find-
ngs. Strict enrollment criteria are used in clinical trials, and
he results observed here might not be applicable to all
atients in clinical practice.
onclusions. Independent of the velocity of antegrade
ow in the epicardial artery, a pulsatile pattern of flow with
etrograde or reversed flow during systole is associated with
mpaired myocardial perfusion and poorer clinical outcome.
his simple and easily identifiable angiographic flow pattern
ay be useful in clinical risk stratification.
eprint requests and correspondence: Dr. C. Michael Gibson,
irector TIMI Data Coordinating Center, 350 Longwood Ave-
ue, 1st Floor, Boston, Massachusetts 02115. E-mail: mgibson@
erfuse.org.
EFERENCES
1. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI
myocardial perfusion grade to mortality after administration of throm-
bolytic drugs. Circulation 2000;101:125–30.
2. Iwakura K, Ito H, Takiuchi S, et al. Alteration in the coronary blood
flow velocity pattern in patients with no reflow and reperfused acute
myocardial infarction. Circulation 1996;94:1269–75.
3. Yamamoro A, Akasaka T, Tamita K, et al. Coronary flow velocity
pattern immediately after percutaneous coronary intervention as a
predictor of complications and in-hospital survival after acute myocar-
dial infarction. Circulation 2002;106:3051–6.
4. Gibson CM, Murphy S, Menown IB, et al. Determinants of coronary
blood flow after thrombolytic administration. J Am Coll Cardiol
1999;34:1403–12.
5. Gibson CM, Ryan KA, Murphy SA, et al. Impaired coronary blood
flow in nonculprit arteries in the setting of acute myocardial infarction.
J Am Coll Cardiol 1999;34:974–82.
6. Cannon CP, McCabe CH, Gibson CM, et al. TNK-tissue plasmin-
ogen activator in acute myocardial infarction: results of the Throm-
bolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.
Circulation 1997;95:351–6.
7. Cannon CP, Gibson CM, McCabe CH, et al. TNK-tissue plasmin-
ogen activator compared with front-loaded alteplase in acute myocar-
dial infarction: results of the TIMI 10B trial. Thrombolysis in
Myocardial Infarction (TIMI) 10B investigators. Circulation 1998;98:
2805–14.
8. Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates
the rate and extent of thrombolysis: results of the thrombolysis in
myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.
Circulation 1999;99:2720–32.
9. Antman EM, Gibson CM, de Lemos JA, et al. Combination
reperfusion therapy with abciximab and reduced dose reteplase: results
from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI)
14 Investigators. Eur Heart J 2000;21:1944–53.
0. Giugliano RP, Roe MT, Harrington RA, et al., for the INTEGRITI
Investigators. Combination reperfusion therapy with eptifibatide and
reduced-dose tenecteplase for ST-elevation myocardial infarction:
results of the integrilin and tenecteplase in acute myocardial infarction
(INTEGRITI) phase II angiographic trial. J Am Coll Cardiol 2003;
41:1251–60ii.
11
1
1
1
1
1
1
1
1176 Gibson et al. JACC Vol. 43, No. 7, 2004
Pulsatile Flow and Clinical Outcomes April 7, 2004:1170–61. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial
Infarction (TIMI) trial, phase I: a comparison between intravenous tissue
plasminogen activator and intravenous streptokinase: clinical findings
through hospital discharge. Circulation 1987;76:142–54.
2. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a
quantitative method of assessing coronary artery flow. Circulation
1996;93:879–88.
3. de Lemos JA, Antman EM, Giugliano RP, et al. ST-segment
resolution and infarct-related artery patency and flow after thrombo-
lytic therapy: Thrombolysis in Myocardial Infarction (TIMI) 14
investigators. Am J Cardiol 2000;85:299–304.
4. Gibson CM, Cannon CP, Piana RN, et al. Angiographic predictors of
early reocclusion in the TIMI 4 trial. J Am Coll Cardiol 1995;25:582–9.
5. Gibson CM, Karha J, Murphy SA, et al. Early and long term clinical
outcomes associated with reinfarction following fibrinolytic adminis-
tration in the TIMI trials. J Am Coll Cardiol 2003;42:7–16.6. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between
TIMI frame count and clinical outcomes after thrombolytic adminis-
tration: Thrombolysis In Myocardial Infarction (TIMI) study group.
Circulation 1999;99:1945–50.
7. Lundergan CF, Reiner JS, McCarthy WS, et al. Clinical predictors of
early infarct-related artery patency following thrombolytic therapy:
importance of body weight, smoking history, infarct-related artery and
choice of thrombolytic regimen: the GUSTO-I experience. J Am Coll
Cardiol 1998;32:641–47.
8. Muller DWM, Topol EJ, Ellis SG, et al. Multivessel coronary
artery disease: a key predictor of short-term prognosis after reper-
fusion therapy for acute myocardial infarction. Am Heart J 1991;
121:1042–9.
9. Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with
abciximab reduces angiographically evident thrombus in acute myocardial
infarction: a TIMI 14 substudy. Circulation 2001;103:2550–4.
